Scleroderma - new aspects in pathogenesis and treatment.
about
Systemic sclerosis: current concepts in pathogenesis and therapeutic aspects of dermatological manifestations.Upregulation of distinct collagen transcripts in post-surgery scar tissue: a study of conjunctival fibrosisInterleukin-17A promotes functional activation of systemic sclerosis patient-derived dermal vascular smooth muscle cells by extracellular-regulated protein kinases signalling pathway.IL-17A induces endothelial inflammation in systemic sclerosis via the ERK signaling pathwayTanshinone IIA attenuates interleukin-17A-induced systemic sclerosis patient-derived dermal vascular smooth muscle cell activation via inhibition of the extracellular signal-regulated kinase signaling pathwayEndothelin Receptors Expressed by Immune Cells Are Involved in Modulation of Inflammation and in Fibrosis: Relevance to the Pathogenesis of Systemic Sclerosis.Endothelin-1 levels in scleroderma patients: a pilot study.Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis.Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells.Hematopoietic stem cell transplantation in children with autoimmune connective tissue diseases.Is there an association between glaucoma and capillaroscopy in patients with systemic sclerosis?Active subcutaneous calcinosis demonstrated by fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in a case of limited cutaneous systemic sclerosis.Clinical and autoantibody profile in systemic sclerosis: baseline characteristics from a West Malaysian cohort.Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis.Combined platelet-rich plasma and lipofilling treatment provides great improvement in facial skin-induced lesion regeneration for scleroderma patients.Adenosine A2A receptor promotes collagen type III synthesis via β-catenin activation in human dermal fibroblasts.Increased expression of NAPDH oxidase 4 in systemic sclerosis dermal fibroblasts: regulation by transforming growth factor β.Increased frequencies of circulating CXCL10-, CXCL8- and CCL4-producing monocytes and Siglec-3-expressing myeloid dendritic cells in systemic sclerosis patients.Asiatic acid prevents the development of interstitial lung disease in a hypochlorous acid-induced mouse model of scleroderma.Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay
P2860
Q31125829-466F11A2-1D3A-49CD-BD32-B30E3A048E38Q33830501-B289D2D8-3978-4660-8D2F-DE4C82812C30Q35047990-60852488-D816-408B-84D1-D7E463019FDEQ35078513-1BCDB505-B0E2-4D14-81B2-6F628F294303Q35565348-D99DF83E-5A03-4EC5-8BB4-D7AEECB2FCBCQ35668241-BFD55058-0A19-491C-A919-8AE88C284C13Q37105347-F6C00723-6896-4273-A290-8284A9FD724AQ37423983-4B561917-F7FE-47ED-AA8D-A2EEBC3ECF60Q37635275-272063E9-7AD7-49FA-ABE0-BBA5D7CDBED7Q38194074-33A1B187-097D-4B53-99E1-E80A02609B3EQ38800209-D4E30139-6A99-4E7E-9ECC-FCE2A8B650CDQ39724099-96EFBB7E-4651-4FBD-ABAE-E13B2E43AE3CQ40176801-BED451E7-A543-4981-8331-9A12D6E75097Q40382703-337B606C-9E6D-485D-A12D-ACF5B209458DQ42654281-E58C35E5-96E8-4142-B7BF-59CBCF7E1A4EQ42693725-8E71B94A-D49D-495D-80AA-D46565CEAA73Q43240966-FD46A7AC-87C9-49C2-8B23-A7BE9E68EC3CQ47614995-886A1255-A120-461B-81EE-C062851A9A51Q54958372-A1AE2B79-CF38-4924-A2B5-C965FCA722B9Q56890795-CDA8C59C-9484-4F4D-A362-ED260A64C960
P2860
Scleroderma - new aspects in pathogenesis and treatment.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Scleroderma - new aspects in pathogenesis and treatment.
@ast
Scleroderma - new aspects in pathogenesis and treatment.
@en
Scleroderma - new aspects in pathogenesis and treatment.
@nl
type
label
Scleroderma - new aspects in pathogenesis and treatment.
@ast
Scleroderma - new aspects in pathogenesis and treatment.
@en
Scleroderma - new aspects in pathogenesis and treatment.
@nl
prefLabel
Scleroderma - new aspects in pathogenesis and treatment.
@ast
Scleroderma - new aspects in pathogenesis and treatment.
@en
Scleroderma - new aspects in pathogenesis and treatment.
@nl
P1476
Scleroderma - new aspects in pathogenesis and treatment.
@en
P2093
Alexandra Balbir-Gurman
Yolanda Braun-Moscovici
P356
10.1016/J.BERH.2012.01.011
P577
2012-02-01T00:00:00Z